Get This Health Care Analyst’s Take On The Drug Pricing Debate And Biotech Picks For 2016


This week we are pleased to be joined by our friend Joe McCann, founder of Slingshot Insights. In this episode, Leigh and Joe weigh in on the current debate over inflated drug pricing (starts at 3:23), discuss updates to the Martin Shkreli story, the disgraced CEO of Turig Pharmaceuticals that kicked off this whole controversy (16:45), and we get Joe’s picks for biotech stocks to watch in 2016 (10:50). 

Reviews

  • Total Score 0%
User rating: 0.00% ( 0
votes )



Leave a Reply

Your email address will not be published. Required fields are marked *